A carregar...
Progress and challenges in CRISPR-mediated therapeutic genome editing for monogenic diseases
There are an estimated 10 000 monogenic diseases affecting tens of millions of individuals worldwide. The application of CRISPR/Cas genome editing tools to treat monogenic diseases is an emerging strategy with the potential to generate personalized treatment approaches for these patients. CRISPR/Cas...
Na minha lista:
| Publicado no: | J Biomed Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Editorial Department of Journal of Biomedical Research
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8038532/ https://ncbi.nlm.nih.gov/pubmed/33402545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7555/JBR.34.20200105 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|